Indometacin Bristol Laboratories (Indometacin)

Indometacin blocks both cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which reduces the production of prostaglandins—key mediators of inflammation, pain, and fever. By lowering prostaglandin levels, it diminishes swelling, discomfort, and temperature elevation associated with inflammatory conditions.

The specific dose and dosing schedule of Indometacin are determined by the prescribing clinician based on the patient’s condition, severity, age, renal and hepatic function, and other individual factors. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Indometacin’s safety profile in pregnancy and lactation is not well established, and it is generally classified as a drug of unknown risk. Healthcare providers usually avoid its use in pregnant or nursing women unless the potential benefit outweighs the possible risk to the fetus or infant.

To request Indometacin Bristol Laboratories, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Indometacin is a potent NSAID with strong anti‑inflammatory activity, often considered more effective for gout flares than ibuprofen or naproxen. However, it may have a higher incidence of gastrointestinal and renal side effects, so clinicians balance efficacy against safety when selecting an NSAID for a particular patient.

Indometacin oral tablets should be stored at room temperature, below 25 °C, in the original blister or bottle. Keep the product away from moisture, direct sunlight, and excessive heat. Ensure the container is tightly closed to maintain stability and potency.

Indometacin is taken orally, usually with a full glass of water. It can be taken with or without food, but taking it with meals or an antacid may reduce stomach irritation. Patients should swallow the tablets whole and not crush or chew them unless instructed otherwise.

Serious adverse events include gastrointestinal ulceration or bleeding, severe renal impairment, hepatotoxicity, life‑threatening skin reactions such as Stevens‑Johnson syndrome, and anaphylaxis. Patients should be monitored for signs of these conditions, and therapy should be stopped immediately if they occur.

Indometacin is contraindicated in individuals with known hypersensitivity to indometacin or other NSAIDs, active gastrointestinal ulcer disease, severe renal or hepatic impairment, and in patients with established cardiovascular disease who are at high risk for thrombotic events. It should also be avoided in the third trimester of pregnancy.